A moderate degree of anaemia is commonly present in patients with rheumatoid arthritis. The anaemia is usually normocytic and hypochromic and the degree of anaemia roughly parallels the activity of the disease (Nilsson, 1948; Jeffrey, 1953a) . Among the varied features described in anaemia associated with arthritis are alterations in plasma volume causing anaemia through hydraemia (Robinson, 1943; Dixon, Ramcharan, and Ropes, 1955) , an increased rate of red cell destruction (Mollison and Paterson, 1949; Bunim, 1954; Freireich, Ross, Bayles, Emerson, and Finch, 1954;  Alexander, Richmond, , and abnormalities in iron and porphyrin metabolism (Jeffrey, 1953b) .
The effect of iron therapy on anaemia in this disease has been studied by several workers. Sinclair and Duthie (1950) reported that haemoglobin levels improved with intravenous iron therapy in cases in which oral iron had proved ineffective. Ross (1950) and Jeffrey (1953a) also reported good results with intravenous iron in this condition but all these workers found numerous cases which failed to respond to this treatment. Jeffrey (1953b) , in a search for prognostic factors which might indicate whether the anaemia in any given case was likely to respond to intravenous iron, was unable to derive any material help from assessment of many clinical and laboratory features of the disease. Another group of workers (Kuhns, Gubler, Cartwright, and Wintrobe, 1950) stated that the anaemia and hypoferraemia of rheumatoid arthritis were not appreciably influenced by intravenous iron.
Reports on the value of intravenous iron in the treatment of this anaemia are conflicting and the indications for its use are not clear. In view of the possible dangers of this type of therapy, especially in patients who are not iron-deficient (Dameshek, 1950; Holly, 1951) , it is desirable that intravenous iron should not be used except in cases of iron-deficiency anaemia. The first steps in the diagnosis of iron deficiency anaemia are examination of peripheral blood smears and calculation of "absolute values": the mean cell volume (M.C.V.) and the mean cell haemoglobin concentration (M.C.H.C.). In iron-deficiency anaemia of long standing, the red cells are hypochromic and microcytic and there is decrease in the M.C.V. and M.C.H.C. Certain conditions, e.g. thalassaemia and the anaemia of chronic infection in which the red cells may be hypochromic, may be confused with chronic iron deficiency from peripheral blood examination alone. In true iron deficiency, however, more specific diagnostic findings are present: the absence of iron from the bone marrow, the absence of iron granules in the normoblasts, and a low serum iron level (Coleman, Stevens, and Finch, 1955) . Coleman and his colleagues state that, in their experience, the most reliable and sensitive diagnostic test for irondeficiency is the absence of iron from the marrow.
Bone marrow examination for iron as a means of assessing body iron stores has been recommended by many workers (Rath and Finch, 1948; Hutchison, 1953; Stevens, Coleman, and Finch, 1953) . Although it is not certain that marrow iron is a fair reflection of total iron storage, reports from workers who have investigated iron storage in the liver or spleen concurrently with marrow examination indicate that iron storage in each case was comparable for the various sites at the time (Pratt and Johnson, 1954; Beutler, Drennan, and Block, 1954) . It is generally agreed that iron deficiency alone of the conditions studied is characterized by absence of marrow iron (Hutchison, 1953; Stevens and others, 1953) . Hutchison (1953) states that the hypochromic anaemia due to iron deficiency can be differentiated from that due to chronic infection or intoxication, by examination of marrow iron. In the former condition there is absence of marrow iron whereas in the latter a varying amount of iron can be demonstrated.
In the work here reported, marrow iron examinations were used to study iron deficiency in cases of rheumatoid arthritis and the effect of intravenous iron on the anaemia in these cases was recorded. The cytology of the bone marrow was also studied, particular attention being paid to the maturation of the erythroid series and to the relation between marrow plasma cell levels and serum globulin concentrations.
Materials and Methods
33 cases, all in-patients, suffering from active rheumatoid arthritis were investigated. Each case was classified as suffering from "slightly active" (+), "moderately active" (+ +), or "very active" (+ + +) disease. In classification, the degree of joint pain and tenderness, the presence of general constitutional disturbance, and the erythrocyte sedimentation rate (E.S.R.) were considered. In each case the initial haemoglobin level was 11 g. per 100 ml. or less, the mean corpuscular haemoglobin con--centration (M.C.H.C.) was 29 per cent. or less, and the mean cell volume (M.C.V.) was within normal limits or diminished. Two rheumatoid patients had previously suffered blood loss from haemorrhoids, but were not bleeding at the time of this investigation. Two control cases with uncomplicated iron deficiency anaemia due to blood loss were also investigated. One had suffered from repeated epistaxis for some months, and the other was anaemic because of menorrhagia.
Bone marrow examination was carried out in each case before the start of iron therapy. Approximately 1 g. of an iron preparation for intravenous use (saccharated oxide of iron in colloidal solution, either "Iviron" or "Ferrivenin", containing 20 mg. colloidal iron per ml.) was administered in from six to ten injections during a period of 8 to 14 days. As iron was given intravenously, the question of absorption from the gastrointestinal tract did not arise. Reticulocyte counts were made on at least two occasions between the 5th and 12th days after the start of iron therapy. The results of treatment were assessed at the end of a test period of 4 to 5 weeks. In eight cases observations were continued at the end of the initial trial period, so that, in some cases, the progress of the anaemia was studied for periods of up to 3 months from starting treatment with iron.
Bone Marrow Examination.-Marrow puncture was performed in the manubrium or first or second pieces of the body of the sternum under local anaesthesia. Smears were made from the first few drops of marrow aspirated, after which a further quantity (0 -5 to 1 ml.) of a mixture of blood and marrow was withdrawn into fixative. Histological sections were prepared from aspirated marrow and were stained for iron by the Prussian blue method, using a modification (Hutchison, 1953) of the technique of Cappell, Hutchison, and Smith (1947) .
Storage iron is present in the bone marrow in two forms: -ferritin and haemosiderin (Pirrie, 1950 Examination of Marrow Smears.-500 nucleated cells were counted and the myeloid :erythroid ratio was determined. In each case, the percentages of the different types of erythroblasts in a count of 100 nucleated erythroid cells were estimated. Many factors (e.g. the wide variation in the normal range of differential counts, the irregular distribution of marrow cells on smears, and dilution with peripheral blood) make minor alterations in marrow cytology difficult to establish (Dacie, 1950a) . Erythroid maturation was studied here by expressing the numbers of different classes of erythroblasts as percentages of the total erythroblast count, rather than as percentages of the total nucleated cells present. In the absence of marked peripheral erythroblastaemia, the factor of dilution with peripheral blood does not affect the accuracy of these differential erythroblast counts (Dacie and White, 1949) .
Other Tests.-Haemoglobin was estimated on samples of venous blood as alkaline haematin in a photoelectric calorimeter, using the artificial standard of Gibson and Harrison (1945) . Reticulocytes were counted by the method of Dacie (1950b (Coleman and others, 1955 Haemo-I globin
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HaemoTherapy globin (g./100 ml.) (g./100 ml.) 11 *8 11 *7 10 2 9.9 13 *8 10 6 11 *8 9-8 12 0 10-7 10 2 11*7 13-1 12 0 13 0 8-3 13 *6 11*2 10-6 11 *7 11 *4 11 *4 10-4 11 *7 10-6 10-7 10-1 9-1 10 7 9 0 9 0 11 *7 10-7 1*2 0 7 *3.9 0 7 *2-8 *3-2 *2-7 *2.7 *2-4 1*4 *2-4 *2.9 *2.1 *2-1 0 7 1 *3 Table I . In eleven cases no stainable marrow iron was present. In ten of these eleven cases the haemoglobin level rose by more than 2 g. per 100 ml. In one patient (Case 14) the rise in haemoglobin was only 1-4 g. per 100 ml. With one exception (Case 10), the patients in this group suffered from only moderately or slightly active disease. The average rise in haemoglobin in the ten cases was less than that seen in the control cases who suffered from uncomplicated iron deficiency anaemia (Table II) . The reticulocyte counts in the arthritic patients were low in comparison with those observed in the control cases (Table III) . (Sinclair and Duthie, 1949, 1950; Ross, 1950; Jeffrey, 1953b) have reported that intravenous iron frequently improves the anaemia associated with arthritis, but Kuhns and others (1950) found that the anaemia was not appreciably influenced by large doses of iron given intravenously. Sinclair and Duthie (1950) noticed a striking fall in the erythrocyte sedimentation rate in many of their cases which responded, a finding which suggests that clinical improvement in the disease could not be excluded as the cause of the rise in haemoglobin. Ross (1950) suggested that a "lag" period existed before intravenous iron produced its maximum effect. The results of iron therapy, Ross claimed, were better after a trial period of 3 months than after one month. The results of follow-up studies in the present series do not bear out Ross's observation, no appreciable haematological improvement taking place so long as disease activity persisted (Table IV) . Though the assessment of haematological improvement by peripheral blood figures alone, without reference to the total circulating haemoglobin as determined by the blood volume, may be fallacious (Whitby and Britton, 1953) , the response of an anaemia to any given therapy is usually judged by the degree of reticulocytosis and by the rise in haemoglobin. Since the degree of reticulocytosis is variable, depending, for example, on the severity of the anaemia, it is usually more appropriate to determine the effectiveness of iron therapy from the rise in haemoglobin (Coleman and others, 1955) . In the present study, the responses to iron therapy in the iron-deficient rheumatoid group are only moderate when compared with those observed in the control cases who suffered from uncomplicated iron deficiency. With one exception, the irondeficient rheumatoid group suffered from only moderately or slightly active disease, and, in general, the degree of anaemia present in this group was out of proportion to the severity of the disease. The higher haemoglobin levels which were found after response to iron therapy were more in keeping with those to be expected if the anaemia had been due to disease activity alone. Stevens (1956) points out that absence of marrow iron, though an indication that iron stores are reduced, does not guarantee that iron deficiency is the only cause of the anaemia. This is the possible explanation, for the poor response to iron therapy of Case 14 in which the marrow was devoid of iron. It might also explain the incomplete response to iron noticed by Jeffrey (1953b) in cases of anaemia associated with rheumatoid arthritis. In these cases, although the blood picture improved after iron therapy, the haemoglobin failed to return to normal. In one case in the present study (Case 18), after an initial response to iron therapy, tne anaemia became refractory to further intravenous iron therapy at ANNALS OF THE RHEUMATIC DISEASES the higher haemoglobin level reached. It is possible that anaemia in certain cases of rheumatoid arthritis is only partially due to iron deficiency. When this iron deficiency is corrected, the residual anaemia in these cases, like the anaemia in the iron-refractory group, may be due to a toxic factor or factors associated with disease activity.
Previous reports on marrow iron stores in cases of rheumatoid arthritis indicate that some marrow iron was present in the majority. Pratt and Johnson (1954) (Jeffrey, 1953a) . Although the importance of alteration in plasma volume in producing a rise in haemoglobin in association with clinical remission in this disease has been stressed (Dixon and others, 1955) , it seems reasonable to assume that, when spontaneous improvement does take place, marrow iron stores are utilized for haemoglobin synthesis. In patients whose iron stores are small, the possibility exists that, should clinical improvement occur, the amount of storage iron might be insufficient to restore the haemoglobin to normal. If this were the case, these patients would then require iron therapy to correct the anaemia.
In the majority of the bone marrows examined, the percentage of basophilic normoblasts was increased (Table V) . A similar change in the erythroid series in cases of rheumatoid arthritis was noted by Nilsson (1948) . This disturbance of maturation was present both in marrows which were devoid of iron and in those which contained iron. The work of Thorell (1947) and of Hammarsten, Thorell, Aqvist, Eliasson, and Akerman (1953) suggests that haemoglobin synthesis starts after the basophilic normoblast stage. The experiments of Lajtha and Suit (1955) , who measured the uptake of radio-iron by nucleated red cells in vitro, indicate that iron uptake is maximal in the late pronormoblast and basophilic normoblast stage. It is possible that the presence of a large percentage of basophilic normoblasts may be indicative of a state in which haemoglobin synthesis is retarded, either because iron is lacking as in iron deficiency, or because of non-utilization of iron as in states characterized by bone marrow dysfunction. This view receives support from the observations of Leitner, 'Britton, and Neumark (1949) that the percentage of basophilic normoblasts is increased in the bone marrow of patients with iron deficiency anaemia. Marrow plasma cell levels were slightly increased in ten of the 33 cases examined in the present study (Table  V) . Marrow plasmacytosis in rheumatoid arthritis has been noted by several authors (Hayhoe and Smith, 1951; Klein and Block, 1953; Richmond and others, 1956 ). In the series of cases examined by Richmond and others (1956) , the marrow plasma cell counts were significantly related to the serum globulin level, though hyperglobulinaemia was not invariably associated with marrow plasmacytosis. The findings in the present study confirm their observations, in that hyperglobulinaemia was not constantly accompanied by marrow plasmacytosis although a raised serum globulin level was always found in cases in which an increase in marrow plasma cells was a feature (Table VI) . Plasmacytosis appears to be a non-specific response, as it is found in neoplastic, granulomatous, infectious, and allergic states (Klein and Block, 1953) . The exact cause of the anaemia in rheumatoid arthritis is not known. A significant increase in plasma volume in anaemic patients with arthritis has been described (Robinson, 1943; Dixon and others, 1955) and an increased rate of red cell destruction has been demonstrated in this disease (Bunim, 1954; Freireich and others, 1954; Alexander and others, 1956) . In a study of the life-span of normal red cells in the circulation of patients with rheumatoid arthritis (McCrea, 1957) , six of the iron refractory group of patients were examined; five of these six patients, Cases 28-32, eliminated normal red cells at two to four times the normal rate. It is unlikely, however, that an increase in plasma volume and an increased rate of red cell destruction could completely account for anaemia in rheumatoid arthritis, particularly in view of the abnormalities in iron metabolism that have been described in this disease (Nilsson, 1948; Jeffrey, 1953b) . In some cases in the present study, iron deficiency played a part in the production of anaemia. The factors responsible for anaemia in the patients who failed to respond to intravenous iron therapy and for the residual anaemia after incomplete response to iron are not completely understood. Though an increased rate of red cell destruction is of importance in causing anaemia in some of these cases, a further fundamental defect is the inability to produce fully haemoglobinized red cells despite the presence of unutilized iron stores. The exact nature of this defect is unknown, but in the present study it was not corrected by intravenous iron therapy.
In this work, a response to iron therapy could not have been predicted from peripheral blood examination alone, as the majority of the patients failed to respond despite the fact that the M.C.H.C. was lowered in each case. A much more reliable indication of the probable success or failure of intravenous iron therapy was afforded by marrow iron examination. Iron was given intravenously rather than orally in the present study so that the question of failure of absorption from the intestinal tract might not arise. It has been shown that absorption of oral iron in anaemic patients with rheumatoid arthritis is normal (Roy, Alexander, and Duthie, 1955) . If this be so, oral iron should be as effective as parenteral iron in the treatment of iron deficiency anaemia associated with rheumatoid arthritis.
Summary
Iron deficiency in rheumatoid arthritis was studied by means of marrow iron examinations using the Prussian blue method. The presence of iron in the bone marrow showed that the majority of cases were not iron deficient although the mean cell haemoglobin concentration (M.C.H.C.) was lowered in each case. The reliability of marrow iron examination as a means of detecting iron deficiency in this disease was confirmed by the results of intravenous iron therapy.
In eleven cases, the bone marrow was devoid of stainable iron. With one exception, the anaemia in these patients responded to intravenous iron by a rise in haemoglobin of more than 2 g. per 100 ml. In 22 cases, a varying amount of marrow iron was demonstrated. The haemoglobin level rose by more than 2 g. per 100 ml. in only one case in this group, and in this patient clinical improvement could not be excluded as the cause of the rise in haemoglobin.
The rise in haemoglobin in iron deficient rheumatoid patients was in general, less than that seen in patients suffering from uncomplicated iron deficiency anaemia. It is suggested that anaemia in some cases of rheumatoid arthritis may be only partially due to iron deficiency. When this iron deficiency is corrected, the residual anaemia, like that in the iron-refractory group, may be due to a toxic factor or factors associated with disease activity.
In many cases there was evidence of a delay in erythroid maturation, in that the number of basophilic normoblasts, expressed as a percentage of total marrow erythroblasts, was increased. This was a feature both of marrows which contained iron and of those which were devoid of iron.
There Examen del hierro medular en el diagnostico de la carencia ferrica en la artritis reumatoide SUMARIO Se estudi6 la deficiencia ferrica en la artritis reumatoide por el examen del hierro en la medula 6sea por el metodo de azul de Prusia. La presencia de hierro en la medula 6sea mostr6 que en la mayoria de los casos no hubo deficiencia ferrica, aunque la concentraci6n media de hemoglobin globular fuese siempre disminuida. Los resultados de administraci6n endovenosa de hierro confirmaron la exactitud del examen del hierro medular como medio de evidenciar la deficiencia ferrica en la artritis reumatoide.
En once casos hierro colorable no fue encontrado en la medula 6sea. Con una excepci6n. Ia anemia en estos enfermos respondi6 a la medicaci6n ferrica endovenosa por un ascenso de la hemoglobin a mas de dos gramos por 100 cc. En 22 casos se evidenciaron cantidades variables de hierro en la medula. En un solo de estos casos la cifra de hemoglobin rebas6 el 2 gramos por 100 cc. y hasta en este caso el aumento podria atribuirse a una mejoria clinica.
El aumento de hemoglobin en los reumaticos con deficiencia ferrica fue generalmente menor que el observado en enfermos con anemia ferripriva simple.
Se suigiere que en ciertos casos de artritis reumatoide la anemia se deberia tan solo en parte a una deficiencia ferrica. Al corregir esta deficiencia, la anemia residual, como en el grupo refractario al hierro podria deberse a uno o mas factores t6xicos asociados a la actividad m6rbida.
En varios casos se vieron signos de demora en la maduraci6n eritroide, en el sentido de que la cifra de normoblastos bas6filos expresada en el porcentaje del total de eritroblastos medulares, fue aumentada. Esto constituy6 un rasgo caracteristico tanto de las medulas que contuvieron hierro como de las que fueron desprovistas de 61.
En 10 de los 33 enfermos investigados encontrose una ligera aumentaci6n en la cifra de los plasmocitos medulares. Al determiner las cifras de globulin serica se observe que la plasmocitosis medular fue siempre asociada a un aumento de estas, aunque una hiperglobulinemia no se vi6 neceseriamente acompanada de plasmocitosis medular.
